Kymera Therapeutics (KYMR) Preferred Dividend Payments (2020)
Kymera Therapeutics' (KYMR) quarterly Preferred Dividend Payments came in at -$50000.0 in Q2 2020, down 100.55% on a QoQ basis from $9.1 million in Q1 2020.
Kymera Therapeutics (KYMR) Preferred Dividend Payments (2020) Analysis & Trends
Kymera Therapeutics (KYMR) has 1 years of Preferred Dividend Payments data on file, last reported at -$50000.0 in Q2 2020.
- On a quarterly basis, Preferred Dividend Payments changed N/A year-over-year to -$50000.0 in Q2 2020; TTM through Dec 2020 was $9.0 million, a N/A change from a year earlier, with the FY2020 full-year figure at $9.0 million, changed N/A from the prior year.
- Preferred Dividend Payments for Q2 2020 stood at -$50000.0, down from $9.1 million in the prior quarter.
- Over the last five years, Preferred Dividend Payments for KYMR reached as high as $9.1 million in Q1 2020 and fell as low as -$50000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Kymera Therapeutics | 10.77 Bn | 10.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -50,000.00 |
| Mar 31, 2020 | 9.10 Mn |